Abstract
Abstract
Human noroviruses (HuNoVs) are the most common cause of non-bacterial foodborne illnesses worldwide. HuNoVs are notoriously difficult to culture, and current cell culture systems, such as human intestinal enteroids have limitations in efficiency and scalability, which has limited their applications in food safety studies. Recently, it has been shown that transformed salivary gland cell lines (including NS-SV-TT-DC) allow for replication and passaging of norovirus GII.4. Herein, we examined whether we can independently observe viral replication in salivary gland cells and if other strains of human norovirus can replicate in these cells. For this purpose, we first evaluated the replication of several norovirus strains in NS-SV-TT-DC cells by either infecting them with vesicle-cloaked viruses or total viruses in stool filtrates. Low levels of viral replication was observed and vesicle isolation did not improve viral replication. Next, we screened for replication of 50 norovirus samples from 9 genotypes, and 14 isolates demonstrated over a two-fold viral replication. We observed that the initial viral load in the samples does not have a significant effect on replication efficiency. We were also able to successfully passage several isolates. Subsequently, we examined whether interferon inhibitors such as Ruxolitinib, TPCA-1, and BX795 would improve viral replication and observed negligible effects. Finally we tested multiple supplements including MgCl
2
, bile salt, ceramide, and TAK-779. Most supplements had little or no effect on HuNoV replication in NS-SV-TT-DC cells. Bile salt and TAK-779 showed limited, genotype-specific benefits. Altogether these results indicate that salivary gland cells allow limited replication of certain HuNoV isolates.
Importance
The lack of robust and accessible cell culture systems continues to hinder human norovirus research. Salivary gland cell lines have recently emerged as a promising alternative to human intestinal enteroids because they are easy to maintain and relatively unexpensive. Here, we provide a large-scale independent evaluation of the NS-SV-TT-DC salivary gland model using 50 clinical isolates from multiple human norovirus genotypes. Although several isolates replicated and could be serially passaged, replication was typically modest. Furthermore, multiple approaches commonly used to enhance viral replication in cell culture had little or no effect on system efficiency. These findings establish realistic expectations for the use of this model and provide a framework for future optimization of human norovirus cultivation systems.